Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial biopharma-reporter.com Submitted by Sorin61 t3_z563cl on November 26, 2022 at 12:10 PM in technology 186 comments 13,682
SirLeto t1_ixw9c5u wrote on November 26, 2022 at 9:37 PM Reply to comment by Altruistic-Ad3704 in Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial by Sorin61 You train immune cells to target the cancer. Permalink Parent 12
Viewing a single comment thread. View all comments